Jazz and AbCellera sign deal for T-cell engagers in solid tumours

Jazz Pharmaceuticals and AbCellera have signed a preclinical research, option, and licence agreement for the discovery and development of TCE multispecific antibodies for GI cancers and other solid tumours.